Cargando…
Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma
SIMPLE SUMMARY: The incidence of the most common metastatic skin malignancy, cutaneous squamous cell carcinoma (cSCC), is growing worldwide, and the prognosis of the metastatic disease is poor. Presently, there are no biomarkers or therapeutic targets for high-risk cSCCs. Recent studies have demonst...
Autores principales: | Rahmati Nezhad, Pegah, Riihilä, Pilvi, Knuutila, Jaakko S., Viiklepp, Kristina, Peltonen, Sirkku, Kallajoki, Markku, Meri, Seppo, Nissinen, Liisa, Kähäri, Veli-Matti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773783/ https://www.ncbi.nlm.nih.gov/pubmed/35053469 http://dx.doi.org/10.3390/cancers14020305 |
Ejemplares similares
-
Complement System in Cutaneous Squamous Cell Carcinoma
por: Riihilä, Pilvi, et al.
Publicado: (2019) -
Super Enhancer-Regulated LINC00094 (SERLOC) Upregulates the Expression of MMP-1 and MMP-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma
por: Piipponen, Minna, et al.
Publicado: (2022) -
Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study
por: KNUUTILA, Jaakko S., et al.
Publicado: (2020) -
Tumour‐cell‐derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma
por: Riihilä, P., et al.
Publicado: (2019) -
Identification of metastatic primary cutaneous squamous cell carcinoma utilizing artificial intelligence analysis of whole slide images
por: Knuutila, Jaakko S., et al.
Publicado: (2022)